|
VPS33A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.604000E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.582700E-03 |
| Normal-vs-Stage2 |
4.022000E-02 |
| Normal-vs-Stage3 |
6.294000E-02 |
| Normal-vs-Stage4 |
3.833500E-02 |
| Stage1-vs-Stage2 |
9.573600E-01 |
| Stage1-vs-Stage3 |
3.497000E-01 |
| Stage1-vs-Stage4 |
7.072600E-01 |
| Stage2-vs-Stage3 |
4.998400E-01 |
| Stage2-vs-Stage4 |
7.561000E-01 |
| Stage3-vs-Stage4 |
7.234600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.600700E-03 |
| Normal-vs-AfricanAmerican |
9.955600E-04 |
| Normal-vs-Asian |
1.294580E-01 |
| Caucasian-vs-AfricanAmerican |
1.840590E-01 |
| Caucasian-vs-Asian |
4.279800E-01 |
| AfricanAmerican-vs-Asian |
5.280200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.470400E-02 |
| Normal-vs-Female |
1.301540E-03 |
| Male-vs-Female |
1.971980E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.460200E-03 |
| Normal-vs-Age(41-60Yrs) |
7.279200E-03 |
| Normal-vs-Age(61-80Yrs) |
4.538200E-02 |
| Normal-vs-Age(81-100Yrs) |
3.384000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.722000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.885400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.887600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.355200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.791000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.992200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.022000E-01 |
| Classical-VS-Follicular |
6.160900E-04 |
| Classical-VS-Other |
4.499900E-02 |
| Classical-VS-Normal |
5.68799999999259E-05 |
| Tall-VS-Follicular |
9.631600E-02 |
| Tall-VS-Other |
1.007030E-01 |
| Tall-VS-Normal |
5.992100E-02 |
| Follicular-VS-Other |
6.250600E-01 |
| Follicular-VS-Normal |
9.244600E-01 |
| Other-VS-Normal |
5.063800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.153800E-02 |
| Normal-vs-N1 |
7.351800E-01 |
| N0-vs-N1 |
1.439610E-01 |
|
|
